Shenzhen Huade Xinrun Equity Investment Enterprise (Limited Partnership) completed the acquisition of 28% stake in Dirui Industrial Co.,Ltd. from Jinjiang Ruifa Investment Co., Ltd.
November 25, 2020
Share
Shenzhen Huade Xinrun Equity Investment Enterprise (Limited Partnership) entered into Equity Transfer Agreement to acquire 28% stake in Dirui Industrial Co.,Ltd. (SZSE:300396) from Jinjiang Ruifa Investment Co., Ltd. for CNY 1.8 billion on August 25, 2020. As on October 30, 2020, 10% of the consideration is paid. In related transactions, Guangdong Guanghengshun Investment Co., Ltd., agreed to acquire 12% and Yi Xiangping, Song Jie and Song Chao agreed to acquire 13.8% stake in Dirui Industrial Co.,Ltd. from Jinjiang Ruifa Investment Co., Ltd. Transaction is subject to Anti-Monopoly Bureau of the State Administration for Market Regulation and related equity transfer matters need to obtain confirmation opinions from the Shenzhen Stock Exchange.
Shenzhen Huade Xinrun Equity Investment Enterprise (Limited Partnership) completed the acquisition of 28% stake in Dirui Industrial Co.,Ltd. (SZSE:300396) from Jinjiang Ruifa Investment Co., Ltd. on November 26, 2020.
DIRUI INDUSTRIAL CO.,LTD is a China-based company principally engaged in the research, development, production and sale of medical testing equipment and supporting test paper and reagents. The Company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series and blood cell analysis series. The Company's products are used for routine physical examination and diagnosis of illness. The Company distributes its products in domestic market and to overseas markets.
DIRUI INDUSTRIAL CO.,LTD. 
